Benefit of liposomal bupivacaine for pain in TKA questioned

June 4, 2018

(HealthDay)—Liposomal bupivacaine use in patients undergoing total knee arthroplasty is not associated with clinically meaningful reductions in inpatient opioid use, resource utilization, or opioid-related complications, according to a study published online May 21 in Anesthesiology.

Lukas Pichler, M.D., from Weill Cornell Medical College in New York City, and colleagues analyzed the impact of liposomal bupivacaine use (regardless of administration route) on inpatient opioid prescription, resource utilization, and opioid-related complications among 88,830 patients undergoing total knee arthroplasties (2013 to 2016) with a peripheral nerve block.

The researchers found that liposomal bupivacaine was used in 21.2 percent of patients. Its use was not associated with a clinically meaningful reduction in inpatient opioid prescription, length of stay, or cost of hospitalization. In addition, liposomal bupivacaine use was not associated with decreased odds of opioid-related complications.

"Given the number of recent publications that suggest a lack of benefit of the addition of liposomal bupivacaine to a multimodal regimen, including a regional analgesic technique, its routine use should be carefully examined, especially given its relatively high cost," the authors write.

Explore further: New form of local anesthetic does not reduce opioid use or complications after knee surgery

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

New form of local anesthetic does not reduce opioid use or complications after knee surgery

May 21, 2018
Contrary to what some studies may suggest, the local anesthetic drug, liposomal bupivacaine, did not reduce in-hospital opioid prescriptions or opioid-related complications in patients who received the drug during total knee ...

Regional anesthesia tied to lower opioid use in TKA, THA

May 24, 2018
(HealthDay)—Regional anesthesia is associated with a lower opioid consumption in both knee and hip replacement surgeries, compared to general anesthesia, according to a study published May 14 in PAIN Practice.

Inpatient opioid use and insufficient weaning pre-discharge may increase outpatient opioid prescript

May 21, 2018
According to the University of Pittsburgh School of Medicine scientists who conducted the study, theirs is the first large-scale evaluation of the impact of in-hospital opioid prescribing on post-discharge opioid use.

Bumps in the road to developing long-lasting, single-injection nerve blocks

October 28, 2013
Can a new liposomal bupivacaine product provide long-lasting nerve block with a single injection? An initial study in humans shows promise—but also some "confusing results," reports the November issue of Anesthesia & Analgesia, ...

Multimodal approach to pain management reduces opioids, prescriptions after joint replacement

March 1, 2018
A multimodal approach to pain management (using two or more different methods or medications to manage pain) rather than using opioids alone was associated with a decrease in opioid use, opioid prescriptions and common opioid-related ...

Longer duration of post-op opioid use associated with misuse

January 19, 2018
(HealthDay)—Each refill and week of opioid prescription following surgery is associated with an increasing risk of opioid misuse among opioid naive patients, according to a study published online Jan. 17 in The BMJ.

Recommended for you

Discovery opens door for synthetic opioids with less addictive qualities

June 1, 2018
Making opioids from sugar instead of from field grown opium poppies has the potential to solve many of the problems associated with manufacturing strong pain killers.

US doctors prescribing fewer opioid painkillers: report

May 31, 2018
US doctors reduced the number of prescriptions for opioid painkillers last year, continuing a five-year trend, in an effort to reverse a deadly drug abuse epidemic, a report released Thursday said.

Researchers publish study on new therapy to treat opioid use disorder

May 22, 2018
Better delivery of medications to treat opioid use disorder (OUD) is key to addressing the opioid crisis and helping the 2.6 million Americans affected by the disease.

Could nonprofit drug companies cut sky-high prices?

May 17, 2018
(HealthDay)—Generic prescription drugs should be cheap, but prices for some have soared in the United States in recent years. Now a group of U.S. hospitals thinks it has a solution: a nonprofit drug maker.

Fewer antibiotics for kids, but more ADHD drugs

May 15, 2018
(HealthDay)—American kids are taking fewer prescription medications these days—but certain drugs are being prescribed more than ever, a new government study finds.

Opioid makers' perks to docs tied to more prescriptions

May 14, 2018
Doctors who accept perks from companies that make opioid painkillers are more likely to prescribe the drugs for their patients, new research suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.